Selected Publications

Erickson CM, Wexler A, Largent EA: Digital Biomarkers for Neurodegenerative Disease. JAMA Neurology 2025 Notes: *peer-reviewed.

Levy, L.M., Wexler, A., Feinsinger, A.: Responsible Neural Technology Development: Ethical Issues and Challenges. Neural Interfaces (Elsevier book) 2025.

Largent, E., Kim, Y., Karlawish, J., Wexler, A: Ethics from the Outset: Incorporating Ethical Consideration into the AI Tech Collaboratories’ Pilot Projects. Journal of Gerontology: Medical Sciences 2025.

Qiu L, Chang A, Ma R, Strong TV, Okun MS, Foote KD, Wexler A, Gunduz A, Miller JL, Halpern CH: Neuromodulation for the treatment of Prader-Willi syndrome–A systematic review. Neurotherapeutics 21(3): e00339, 2024.

Largent E, Karlawish J, Wexler A : From an idea to the marketplace: Identifying and addressing ethical and regulatory considerations across the digital health product-development lifecycle. BMC Digital Health 2(1): 41, 2024.

Wexler A: My digital refuge. JAMA 331(20): 1707-08, 2024.

Wexler A: The ethical implications of Elon Musk’s unorthodox approach to medical science. STAT 2024 Notes: https://www.statnews.com/2024/07/08/neuralink-elon-musk-scientific-ethics-brain-computer-interface/

Wexler A, Feinsinger A: Ethical challenges in Translating Brain-Computer Interfaces. Nature Human Behavior 8(10): 1831-33, 2024.

Colt S, Choi R, Wexler A : To Counsel or Not to Counsel: Physician Attitudes and Experiences with Do-it-yourself (DIY) Fecal Microbiota Transplant (FMT). AJOB Empirical Bioethics 15(4): 324-35, 2024.

Nagappan A, Kalokairinou L, Wexler A: Ethical issues in direct-to-consumer healthcare: A scoping review. PLOS Digital Health 3(2): e0000452, 2024.